Lisa Cuba

7PUBLICATIONS
22CO-AUTHORS
Toxicology (incl. clinical toxicology)Molecular targetsPharmaceutical delivery technologiesInfant and child healthGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 17, 2026
Nationwide validation of the CLEO tool to evaluate the relevance of pharmacists' interventions in German hospitals.

Vivien Berger, Annika van der Linde, Lisa Cuba

|Dec 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data.

Michael I Sponfeldner, Pauline Dürr, Phyllis Lensker

|Jul 18, 2025
Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics.

Lisa Cuba, Frank Dörje, Rafaela Kramer

|Dec 05, 2024
Medication safety with oral antitumour therapeutics in paediatrics (youngAMBORA): A mixed-methods approach towards a tailored care program.

Phyllis Lensker, Lisa Cuba, Katja Gessner

|Jun 07, 2024
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center.

Lisa Cuba, Pauline Dürr, Katja Gessner

|Apr 24, 2024
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy.

Lisa Cuba, Pauline Dürr, Frank Dörje

Pageof 2

Frequent Collaborators

5 joint publications

Pauline Dürr

5 joint publications

Frank Dörje

4 joint publications

Martin F Fromm

3 joint publications

Katja Schlichtig